Literature DB >> 21145973

Negative impact of rAAV2 mediated expression of SOCS3 on the regeneration of adult retinal ganglion cell axons.

M Hellström1, J Muhling, E M Ehlert, J Verhaagen, M A Pollett, Y Hu, A R Harvey.   

Abstract

Intravitreal injections of recombinant ciliary neurotrophic factor (rCNTF) protect adult rat retinal ganglion cells (RGCs) after injury and stimulate regeneration, an effect enhanced by co-injection with a cAMP analogue (CPT-cAMP). This effect is partly mediated by PKA and associated signaling pathways, but CPT-cAMP also moderates upregulation of suppressor of cytokine signaling (SOCS) pathways after rCNTF injection, which will also enhance the responsiveness of RGCs to this and perhaps other cytokines. We now report that intravitreal injections of CPT-cAMP do not potentiate RGC axonal regeneration when CNTF is expressed via an adeno-associated viral vector (rAAV2), and concomitantly we show that increases in retinal SOCS mRNA expression are less when CNTF is delivered using the vector. We also directly tested the impact of elevated SOCS3 expression on the survival and regeneration of injured adult RGCs by injecting a bicistronic rAAV2-SOCS3-GFP vector into the vitreous of eyes in rats with a peripheral nerve graft sutured onto the cut optic nerve. Overexpression of SOCS3 resulted in an overall reduction in axonal regrowth and almost complete regeneration failure of RGCs transduced with the rAAV2-SOCS3-GFP vector. Furthermore, rAAV2-mediated expression of SOCS3 abolished the normally neurotrophic effects elicited by intravitreal rCNTF injections. In summary, CNTF delivery to the retina using viral vectors may be more effective than bolus rCNTF injections because the gene therapy approach has a less pronounced effect on neuron-intrinsic SOCS repressor pathways. Our new gain of function data using rAAV2-SOCS3-GFP demonstrate the negative impact of enhanced SOCS3 expression on the regenerative potential of mature CNS neurons.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145973     DOI: 10.1016/j.mcn.2010.12.003

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  21 in total

Review 1.  Molecular and Cellular Mechanisms of Axonal Regeneration After Spinal Cord Injury.

Authors:  Erna A van Niekerk; Mark H Tuszynski; Paul Lu; Jennifer N Dulin
Journal:  Mol Cell Proteomics       Date:  2015-12-22       Impact factor: 5.911

2.  TNFα and SOCS3 regulate IRS-1 to increase retinal endothelial cell apoptosis.

Authors:  Youde Jiang; Qiuhua Zhang; Carl Soderland; Jena J Steinle
Journal:  Cell Signal       Date:  2012-01-12       Impact factor: 4.315

3.  Spinal cord injury and the neuron-intrinsic regeneration-associated gene program.

Authors:  Nitish D Fagoe; Jessica van Heest; Joost Verhaagen
Journal:  Neuromolecular Med       Date:  2014-10-01       Impact factor: 3.843

4.  Conditional genetic deletion of PTEN after a spinal cord injury enhances regenerative growth of CST axons and motor function recovery in mice.

Authors:  Camelia A Danilov; Oswald Steward
Journal:  Exp Neurol       Date:  2015-02-20       Impact factor: 5.330

5.  Chemokine CCL5 promotes robust optic nerve regeneration and mediates many of the effects of CNTF gene therapy.

Authors:  Lili Xie; Yuqin Yin; Larry Benowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

6.  Protective role of STAT3 in NMDA and glutamate-induced neuronal death: negative regulatory effect of SOCS3.

Authors:  Keun W Park; Susan E Nozell; Etty N Benveniste
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

7.  Extrinsic and intrinsic determinants of nerve regeneration.

Authors:  Toby A Ferguson; Young-Jin Son
Journal:  J Tissue Eng       Date:  2011-09-13       Impact factor: 7.813

8.  A gene network perspective on axonal regeneration.

Authors:  Ronald E van Kesteren; Matthew R J Mason; Harold D Macgillavry; August B Smit; Joost Verhaagen
Journal:  Front Mol Neurosci       Date:  2011-11-22       Impact factor: 5.639

9.  Long-term gene therapy causes transgene-specific changes in the morphology of regenerating retinal ganglion cells.

Authors:  Jennifer Rodger; Eleanor S Drummond; Mats Hellström; Donald Robertson; Alan R Harvey
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

10.  The Acquisition of Target Dependence by Developing Rat Retinal Ganglion Cells

Authors:  Colette Moses; Lachlan P G Wheeler; Chrisna J LeVaillant; Anne Kramer; Marisa Ryan; Greg S Cozens; Anil Sharma; Margaret A Pollett; Jennifer Rodger; Alan R Harvey
Journal:  eNeuro       Date:  2015-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.